Building Research in Implementation and Dissemination to close Gaps and achieve Equity in Cancer Control (BRIDGE-C2) Administrative Supplement

在实施和传播方面开展研究，以缩小差距并实现癌症控制的公平性 (BRIDGE-C2) 行政补充文件

• 批准号: 10173282
• 负责人: Jennifer E DeVoe
• 金额: $ 16.42万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-19 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10173282
• 关键词: Address; Administrative Supplement; Adopted; Adoption; COVID-19; COVID-19 pandemic; Cancer Control; Caring; County; Data; Development; Disease Outbreaks; Electronic Health Record; Evidence based intervention; Funding; Future; Geography; Grant; Guidelines; Health Sciences; Healthcare; Infrastructure; Institutes; Interview; Investigation; Laboratories; Malignant Neoplasms; Methods; Monitor; Neighborhood Health Center; Office Visits; Oregon; Patients; Persons; Positioning Attribute; Prevention; Prevention Guidelines; Preventive Intervention; Preventive care; Primary Health Care; Process; Recommendation; Research; Research Personnel; Screening for cancer; Structure; Telephone; Time; Variant; Visit; Vulnerable Populations; Work; cancer prevention; care delivery; evidence base; health care delivery; health disparity; implementation science; implementation strategy; improved; innovation; insight; interest; member; multidisciplinary; operation; pandemic disease; parent grant; practice-based research network; primary care setting; programs; response; training opportunity

This supplement will explore how the COVID-19 pandemic is impacting cancer screening and prevention (i.e., cancer preventive care) among patients receiving care in community health centers (CHCs) by leveraging the The Building Research in Implementation and Dissemination to close Gaps and achieve Equity in Cancer Control (BRIDGE-C2 ) Center Implementation Laboratory infrastructure. CHCs adapted and changed the way they deliver care during the current pandemic. For example, our Laboratory CHCs showed an 80% decline of in-person office visits, March to April 2020, in which cancer preventive care is typically delivered. This supplement will allow our team to collect the data needed to inform and align the research of our BRIDGE-C2 Center Parent Grant with the new realities of providing healthcare during the COVID-19 pandemic. We will track and understand the implementation strategies made by CHCs to change healthcare delivery processes and priorities, especially cancer preventive care, and share these critical lessons with a variety of stakeholders including the Implementation Science Centers in Cancer Control Program (ISC3 ) and CHCs across the US. With this supplement we will extend the work of our Parent Grant to answer the following questions: (1) What impact has COVID-19 had on the delivery of cancer preventive care; (2) What are the within and across state variations in CHC response to local levels of the COVID-19 outbreak and state / county actions; (3) What processes did CHCs use to adapt existing or adopt new strategies and implement operational changes to realign care with cancer preventive care guidelines in the COVID-19 context; and, (4) How do these findings inform BRIDGE-C2 Center’s future work? Once answered, more questions will become apparent leading to larger scale investigations and additional requests for grant funding. The BRIDGE-C2 Center with its national Implementation Laboratory of geographically diverse CHCs caring for over 1.9 million patients impacted by health disparities is uniquely positioned to extend its Parent Grant to quickly answer these important questions. The Aims of this supplement are: Aim 1: Identify and monitor the impact of the COVID-19 pandemic on delivery and receipt of cancer preventive care over a 12-month period; Aim 2: Identify the processes CHCs used, the external support and assistance they received to implement and adapt cancer preventive care to the COVID19 pandemic context, and operational changes employed to realign care with cancer prevention guidelines; and, Aim 3: Rapidly disseminate findings to a variety of relevant stakeholders. This supplemental work will: (1) advance implementation science by understanding how local adaptations were rapidly implemented or deimplemented in a crisis; (2) guide cancer prevention recommendations on identifying new or adapted ways to deliver cancer preventive care; and (3) rapidly distill and widely disseminate critical implementation findings to NCI laboratories and centers, CHCs and other primary care settings.

该补充剂将探讨如何通过利用建筑研究的实施和传播来弥合差距并实现癌症控制中的公平性（桥接C2）中心实施实验室基础建筑，如何利用建筑物研究来影响社区卫生中心（CHC）的患者中的癌症筛查和预防（即癌症预防保健）。 CHC适应并改变了他们在当前大流行期间提供护理的方式。例如，我们的实验室CHC显示，在3月至2020年4月，通常会提供癌症预防性护理的面对面访问下降80％。这种补充剂将使我们的团队能够收集所需的数据，以告知和对齐我们的桥梁C2中心父母赠款的研究，以及在COVID-19大流行期间提供医疗保健的新现实。我们将跟踪和了解CHC为改变医疗保健提供过程和优先事项（尤其是癌症预防性护理）制定的实施策略，并与各种利益相关者分享这些关键课程，包括癌症控制计划的实施科学中心（ISC3）和美国CHC。通过这种补充，我们将扩大父母赠款的工作，以回答以下问题：（1）Covid-19对癌症预防护理的提供有何影响； （2）CHC对COVID-19-19-19爆发和州 /县行动的地方响应的内部和各州跨州差异是什么； （3）CHC使用哪些过程来适应现有或采用新的策略并在COVID-19环境中使用癌症预防性护理指南进行重新调整以进行重新调查； （4）这些发现如何为Bridge-C2中心的未来工作提供信息？一旦回答，更多的问题将变得显而易见，导致大规模调查和授予资金的其他请求。桥梁C2中心及其国家实施的地理上不同的CHC实施实验室，载有超过190万患者受健康差异影响的患者，可以扩展其父母赠款，以快速回答这些重要问题。该补充的目的是：目标1：确定和监测COVID-19-19的影响在12个月内交付和接收癌症预防性护理的影响；目标2：确定CHC所使用的过程，他们获得的外部支持和援助，以实施和适应Covid19大流行环境，以及使用癌症预防指南重新调整护理的运营变化；并且，目标3：迅速向各种相关利益相关者传播发现。这项补充工作将：（1）通过了解如何在危机中迅速实施或退化的当地适应来提前实施科学； （2）指导预防癌症的建议，以识别提供新的或适应的方法来提供癌症预防治疗； （3）迅速蒸馏并广泛传播给NCI实验室和中心，CHC和其他初级保健环境的关键实施结果。